Senior Clinical Research Associate — Hybrid Growth

Psi CRO; Saint-Maur-des-Fossés; On-site; EUR 45,000 - 65,000; Full time

Benefits offered by this job

Home-office option

Hybrid work

Onboarding trainings

Professional development

RTT days

Job summary

PSI CRO in France seeks a Clinical Research Associate II/Senior CRA to conduct onsite monitoring across therapeutic indications and support study start-up activities. The role emphasizes high-quality data, vendor coordination, and collaboration with internal teams to keep studies on track.

Ideal candidates will have independent on-site monitoring experience in France, Phase II/III expertise, and a strong command of English.

Qualifications

• Independent on-site monitoring experience in France.
• Experience in Phase II/III monitoring visits.
• Experience in oncology, hemophilia, infectious diseases, GI.
• Full working proficiency in English.
• Proficiency in MS Office applications.
• Ability to travel and work in a dynamic team.

Responsibilities

• Conduct and report all types of onsite monitoring visits
• Be involved in study startup
• Perform CRF review, source document verification and query resolution
• Be responsible for site communication and management
• Be a point of contact for in-house support services and vendors
• Communicate with internal project teams regarding study progress
• Participate in feasibility research
• Support regulatory team in preparing documents for study submissions

Skills

English

MS Office

Communication

Collaboration

Problem solving

Travel flexibility

Education

Life sciences degree

Job description

PSI CRO in France seeks a Clinical Research Associate II/Senior CRA to conduct onsite monitoring across therapeutic indications and support study start-up activities. The role emphasizes high-quality data, vendor coordination, and collaboration with internal teams to keep studies on track.

Ideal candidates will have independent on-site monitoring experience in France, Phase II/III expertise, and a strong command of English.